GCP
ATNM icon

GSA Capital Partners’s Actinium Pharmaceuticals ATNM Stock Holding History

GSA Capital Partners’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,673
Closed -$341K – 1397
2021
Q4 		$341K Sell
56,673
-11,532
-17% -$86.5K 0.04% 851
2021
Q3 		$604K Buy
68,205
+21,108
+45% +$147K 0.06% 585
2021
Q2 		$373K Buy
47,097
+8,091
+21% +$63.5K 0.04% 807
2021
Q1 		$297K Buy
+39,006
New +$331K 0.05% 652
2020
Q4 		– Sell
-13,823
Closed -$134K – 1197
2020
Q3 		$134K Buy
+13,823
New +$152K 0.02% 1087
2016
Q3 		– Sell
-4,647
Closed -$247K – 1758
2016
Q2 		$247K Buy
+4,647
New +$259K 0.01% 1484

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return